Does Anticomplement Therapy Have a Role in the Management of Malignant Hypertension?

J Clin Hypertens (Greenwich). 2016 Apr;18(4):359-60. doi: 10.1111/jch.12664. Epub 2015 Sep 11.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Blood Pressure / drug effects*
  • Complement Inactivator Proteins / therapeutic use*
  • Humans
  • Hypertension, Malignant / drug therapy*
  • Hypertension, Malignant / physiopathology
  • Male
  • Middle Aged

Substances

  • Complement Inactivator Proteins
  • anticomplement